Lam Research Corporation

(NASDAQ Global Select)
Slightly Bullish +25

Assetmark Inc. Increases Stake in Lam Research Corporation $LRCX

πŸ“ˆ Assetmark Inc. boosted its LRCX holdings by 146.3% in Q1, adding 196,979 shares to a total position worth $70.85 million.

🏦 Multiple institutional investors including PMV Capital Advisers and Bayban established new stakes in Lam Research during the fourth quarter.

πŸ“‰ Cedar Mountain Advisors increased its LRCX stake by 242.9% in Q1, though its total holding remains small at just 120 shares.

πŸ’° Lam Research shares opened at $313.30, trading between its 50-day moving average of $339.57 and 200-day average of $268.94.

πŸ“Š The company holds a market cap of $391.80 billion with a PEG ratio of 1.90 and a beta of 1.80.

πŸ’΅ Lam Research declared a quarterly dividend of $0.26 per share, paid on July 8th to investors of record from June 17th.

πŸ“‰ Weiss Ratings downgraded LRCX from 'buy (b)' to 'buy (b-)', while Wall Street Zen downgraded it from 'buy' to 'hold'.

πŸš€ Needham & Company raised its price target on Lam Research from $300.00 to $390.00 and maintained a 'buy' rating.

πŸ“‰ Evercore increased its price target from $275.00 to $300.00 with an 'outperform' rating, whereas Erste Group lowered its rating to 'hold'.

πŸ“‰ Director Abhijit Y. Talwalkar sold 18,282 shares worth $6.12 million under a pre-arranged Rule 10b5-1 trading plan.

πŸ“‰ Director Eric Brandt sold 54,500 shares worth $19.12 million, reducing his direct ownership by 21.48%.

πŸ“‰ Insiders have collectively sold 104,621 shares valued at $33.8 million over the last 90 days.

🏭 Lam Research is a global supplier of wafer fabrication equipment for logic and memory manufacturers founded in 1980.

βš™οΈ The company develops systems for thin film deposition, plasma etch, wafer cleaning, and related process modules.

πŸ“ˆ Institutional investors and hedge funds currently own 84.61% of Lam Research's outstanding stock.

Bullish Signals
  • Assetmark Inc. significantly increased its stake in LRCX by 146.3% in Q1, signaling strong institutional confidence in the company.
  • Needham & Company raised its price target on Lam Research to $390.00 and reaffirmed a 'buy' rating.
  • Evercore increased its price target from $275.00 to $300.00 with an 'outperform' rating, indicating positive analyst sentiment.
  • Lam Research maintains a robust balance sheet with a current ratio of 2.54 and a low debt-to-equity ratio of 0.35.
  • The company has a high institutional ownership of 84.61%, suggesting stability and broad market interest.
Risk Factors
  • Director Abhijit Y. Talwalkar sold 18,282 shares worth $6.12 million, reducing his ownership by 17.34%.
  • Director Eric Brandt sold 54,500 shares worth $19.12 million, representing a 21.48% decrease in his position.
  • Insiders have sold a total of 104,621 shares valued at $33.8 million over the last 90 days.
  • Weiss Ratings downgraded Lam Research from 'buy (b)' to 'buy (b-)', reflecting some caution among analysts.
  • Wall Street Zen downgraded Lam Research from a 'buy' rating to a 'hold' rating in May.
  • Erste Group Bank lowered its rating on LRCX shares from 'buy' to 'hold' in April.
Full Analysis
Assetmark Inc. significantly increased its stake in Lam Research Corporation (LRCX) by 146.3% during the first quarter, purchasing an additional 196,979 shares to hold a total position valued at $70.85 million. Several other institutional investors, including PMV Capital Advisers, Bayban, and Vermillion Wealth Management, also established new positions in the semiconductor equipment maker during the fourth or first quarters, while Cedar Mountain Advisors grew its stake by 242.9%. Lam Research shares opened at $313.30 on Friday, trading below its 50-day moving average of $339.57 but above its 200-day average of $268.94. The company maintains a market capitalization of $391.80 billion with a price-to-earnings ratio of 59.11 and a PEG ratio of 1.90. Financial metrics indicate a strong balance sheet with a current ratio of 2.54, a quick ratio of 1.77, and a low debt-to-equity ratio of 0.35. Analyst sentiment remains mixed but generally positive, with the consensus target price set at $358.67 based on ratings from twenty-eight analysts. While some firms like Weiss Ratings and Wall Street Zen downgraded their ratings recently, Needham & Company raised its price target to $390.00 and Evercore increased its target to $300.00. The company recently paid a quarterly dividend of $0.26 per share, resulting in an annualized yield of 0.3%.